Xgene Pharmaceutical Inc.
PrivateLast Round
Series C
Nov 4, 2021
Total Funding Raised
$60M
Company Overview
Xgene Pharmaceutical Inc. operates in Healthcare & Life Sciences and is based in Taipei. Its latest recorded funding round was a Series C round in November 2021.
Xgene Pharmaceutical Inc. is a biotechnology company that develops innovative, multimodal conjugated small molecule drugs to treat neurological disorders and chronic pain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xgene Pharmaceutical Inc. Comparables
Compare Xgene Pharmaceutical Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Latigo Biotherapeutics | 87% | |
| Kallyope | 78% | |
| PharmNovo AB | 77% |
For institutional investors. Book with your work email.
Xgene Pharmaceutical Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Nov 4, 2021 | ||||
| Series B Extension | May 4, 2019 | ||||
| Series B | Oct 1, 2018 |
For institutional investors. Book with your work email.
Xgene Pharmaceutical Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Taiwania Capital | Series B Extension |
| CITIC Securities | Series C |
| TF Capital | Series B, Series A |
| Ping An Ventures | Series C, Series B |
| Hengxu Capital | Series C |
| 5Y Capital | Series B, Series A |
| Yijing Capital | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 4, 2021
$40M round led by CITIC Securities, Hengxu Capital, and Neovision Capital.
- May 4, 2019
Taiwania Capital participated in the round.
For institutional investors. Book with your work email.
Xgene Pharmaceutical Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Xgene Pharmaceutical Inc.'s valuation, stock price, and market status.
Is Xgene Pharmaceutical Inc. a public or private company?
Xgene Pharmaceutical Inc. is a private company.
What is the current stock price of Xgene Pharmaceutical Inc.?
Xgene Pharmaceutical Inc. is a private company, so its shares have no public market price. Caplight tracks Xgene Pharmaceutical Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Xgene Pharmaceutical Inc. worth (valuation)?
Valuation information for Xgene Pharmaceutical Inc. is not publicly available.
Can I buy Xgene Pharmaceutical Inc. stock?
Xgene Pharmaceutical Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Xgene Pharmaceutical Inc.'s last funding round?
Xgene Pharmaceutical Inc.'s most recent funding round was Series C on November 4, 2021.
Who are the main investors in Xgene Pharmaceutical Inc.?
Key investors in Xgene Pharmaceutical Inc. include CITIC Securities, Ping An Ventures, Hengxu Capital, Neovision Capital.
Will Xgene Pharmaceutical Inc. IPO soon?
No public IPO plans have been announced for Xgene Pharmaceutical Inc..
How can I track Xgene Pharmaceutical Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Xgene Pharmaceutical Inc.'s shares on secondary markets.